F. Tas Et Al. , "Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer," TUMOR BIOLOGY , vol.35, no.9, pp.9303-9309, 2014
Tas, F. Et Al. 2014. Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer. TUMOR BIOLOGY , vol.35, no.9 , 9303-9309.
Tas, F., Karabulut, S., Bilgin, E., Tastekin, D., & Duranyildiz, D., (2014). Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer. TUMOR BIOLOGY , vol.35, no.9, 9303-9309.
Tas, Faruk Et Al. "Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer," TUMOR BIOLOGY , vol.35, no.9, 9303-9309, 2014
Tas, Faruk Et Al. "Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer." TUMOR BIOLOGY , vol.35, no.9, pp.9303-9309, 2014
Tas, F. Et Al. (2014) . "Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer." TUMOR BIOLOGY , vol.35, no.9, pp.9303-9309.
@article{article, author={Faruk TAŞ Et Al. }, title={Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer}, journal={TUMOR BIOLOGY}, year=2014, pages={9303-9309} }